Comparison of Dantrolene Sodium with Erythromycin Estolate Using Primary Cultures of Rat Hepatocytes
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 8 (4) , 219-237
- https://doi.org/10.3109/01480548509038647
Abstract
Using primary cultures of parenchymal hepatocytes as a model system, the cytotoxic potential of dantrolene sodium (DS) was compared with that of erythromycin estolate (EE)—a known hepatotoxin. Parallel morphological and functional comparisons were made, following 4-, B-, or 24-h exposures of hepatocyte cultures, using phase contrast microscopy and lactate dehydrogenase (LOH) leakage, respectively. Four-hour exposures of cultures to rather low concentrations of EE (i. e. 50 μM) resulted in cellular necrosis and significantly elevated LDH release. As the concentration of this hepatotoxin was increased, the changes were more pronounced. However, even 4-or 8-h exposures of cultures to a maximum of 100 μM DS did not affect LDH leakage or morphological integrity, although marginally detectable morphological changes did occur at the highest concentration after 24-h. The value of using primary parenchymal hepatocyte cultures as a model system for the assessment of xenobiotic-induced hepatotoxicity was confirmed.This publication has 39 references indexed in Scilit:
- Hepatotoxicological Evaluation of Dantrolene SodiumDrug and Chemical Toxicology, 1984
- Dantrolene sodium: Effects on isolated cardiac tissuesJournal of Molecular and Cellular Cardiology, 1983
- Effects of dantrolene sodium on the contractil properties of isolated guinea-pig pyel-ureterPharmacological Research Communications, 1982
- Erythromycin Estolate vs. Erythromycin Base, Surface Excess Properties and Surface Scanning Changes in Isolated Liver Cell SystemsPharmacology, 1980
- The effects of dantrolene sodium on excretory function in the isolated perfused rat liver*1Toxicology and Applied Pharmacology, 1978
- Hepatotoxic and cellular uptake interactions among surface active components of erythromycin preparationsBiochemical Pharmacology, 1978
- Dantrolene-Associated Hepatic InjuryGastroenterology, 1977
- Evaluation of a Muscle Relaxant: Dantrolene Sodium (Dantrium)JAMA, 1975
- Toxicity of a hepatotoxic laxative preparation in tissue culture and excretion in bile in manClinical Pharmacology & Therapeutics, 1972
- HEPATIC DYSFUNCTION ASSOCIATED WITH TRIACETYLOLEANDOMYCIN AND PROPIONYL ERYTHROMYCIN ESTER LAURYL SULFATEThe Lancet Healthy Longevity, 1962